Literature DB >> 1389892

An artificial amino acid radiopharmaceutical for single photon emission computed tomographic study of pancreatic amino acid transports 123I-3-iodo-alpha-methyl-L-tyrosine.

K Kawai1, Y Fujibayashi, Y Yonekura, J Konishi, H Saji, A Kubodera, A Yokoyama.   

Abstract

123I-3-iodo-alpha-methyl-L-tyrosine (123I-L-AMT) was selected and its characteristics on pancreas accumulation, metabolic selectivity and metabolic stability of 125I-L-AMT were studied. The studies on rat tissue slice as well as mouse biodistribution proved very high accumulation of 125I-labeled L-AMT in the pancreas, which was remarkably inhibited by the active transport inhibitor, ouabain. 125I-L-AMT does not enter into protein synthesis and general amino acid catabolism. Moreover, 125I-L-AMT was very stable against enzymatic deiodination. Thus, the above studies indicated that the 123I-labeled L-AMT was an "artificial amino acid" radiopharmaceutical to be used for the selective measurement of the membrane amino acid transport rate in the pancreas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1389892     DOI: 10.1007/bf03178309

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  22 in total

1.  Amino acid transport models: renal resorption and resistance to metabolic attack.

Authors:  H N CHRISTENSEN; J C JONES
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

2.  The metabolism of iodotyrosines. I. The fate of mono- and di-iodotyrosine in normal subjects and in patients with various diseases.

Authors:  J B STANBURY; A A KASSENAAR; J W MEIJER
Journal:  J Clin Endocrinol Metab       Date:  1956-06       Impact factor: 5.958

3.  Incorporation pattern of L-, D-, and DL-amino acids into the pancreas of mice.

Authors:  R Goto; M Tezuka; O Tamemasa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1977-07       Impact factor: 1.645

4.  A radiopharmaceutical for pancreatic exocrine functional diagnosis: 62Zn-EDDA metabolism in pancreas.

Authors:  Y Fujibayashi; H Saji; K Kawai; Y Unuma; S Miyata; T Okuno; R Hosotani; K Inoue; H Adachi; K Horiuchi
Journal:  Int J Nucl Med Biol       Date:  1986

5.  62Zn-EDDA: a radiopharmaceutical for pancreatic functional diagnosis.

Authors:  Y Fujibayashi; H Saji; I Yomoda; K Kawai; K Horiuchi; H Adachi; K Torizuka; A Yokoyama
Journal:  Int J Nucl Med Biol       Date:  1986

6.  A new approach toward a pancreas-seeking zinc radiopharmaceutical. II. 62Zn-EDDA (ethylenediamine-N,N'-diacetic acid) for pancreas PCT imaging.

Authors:  Y Fujibayashi; H Saji; I Yomoda; K H Suzuki; K Torizuka; A Yokoyama
Journal:  Eur J Nucl Med       Date:  1986

7.  [Metabolic studies of p-iodophenylalanine in the pancreas: a gateway to the development of radioiodinated amino acids for functional diagnosis].

Authors:  K Kawai; Y Fujibayashi; H Saji; J Konishi; A Yokoyama
Journal:  Kaku Igaku       Date:  1988-11

8.  A strategy for the study of cerebral amino acid transport using iodine-123-labeled amino acid radiopharmaceutical: 3-iodo-alpha-methyl-L-tyrosine.

Authors:  K Kawai; Y Fujibayashi; H Saji; Y Yonekura; J Konishi; A Kubodera; A Yokoyama
Journal:  J Nucl Med       Date:  1991-05       Impact factor: 10.057

9.  Evaluation of [1-11C]-alpha-aminoisobutyric acid for tumor detection and amino acid transport measurement: spontaneous canine tumor studies.

Authors:  R E Bigler; P B Zanzonico; B Schmall; P S Conti; J R Dahl; L Rothman; G Sgouros; E G MacEwen
Journal:  Eur J Nucl Med       Date:  1985

10.  Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). I. Autoradiographic study on the distribution of 14 C-labeled D- and L-DOPA and dopamine after intravenous administration in rats.

Authors:  H Shindo; N Miyakoshi; I Takahashi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1971-12       Impact factor: 1.645

View more
  1 in total

1.  Canine SPECT studies for cerebral amino acid transport by means of 123I-3-iodo-alpha-methyl-L-tyrosine and preliminary kinetic analysis.

Authors:  K Kawai; Y Fujibayashi; Y Yonekura; K Tanaka; H Saji; J Konishi; A Kubodera; A Yokoyama
Journal:  Ann Nucl Med       Date:  1995-02       Impact factor: 2.668

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.